Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.34 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20955972 | 0.97 | MEN1 (0.33) | MEN1KMT2ABLMMAPT | |
| SCHEMBL17461579 | 0.87 | SMN1; SMN2 (0.37) | MEN1KMT2ABLM | |
| SCHEMBL18772327 | 0.83 | ALDH1A1 (0.46) | MEN1KMT2AMAPT | |
| SCHEMBL1324591 | 0.79 | SMN1; SMN2 (0.33) | — | |
| SCHEMBL20955975 | 0.79 | MTNR1A (0.31) | — | |
| SCHEMBL22039598 | 0.78 | — | — | |
| SCHEMBL17461572 | 0.77 | TSHR (0.39) | — | |
| SCHEMBL17979599 | 0.76 | — | — | |
| SCHEMBL164146 | 0.76 | — | — | |
| SCHEMBL13996172 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9481695-B2 | Amino acid-modified siloxanes, process for preparing them and application | EVONIK INDUSTRIES AG (DE) | 2016-11-01 | — | — | US | disclosed |
| US-20150023900-A1 | AMINO ACID-MODIFIED SILOXANES, PROCESS FOR PREPARING THEM AND APPLICATION | EVONIK INDUSTRIES AG (DE) | 2015-01-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150023900-A1 | AMINO ACID-MODIFIED SILOXANES, PROCESS FOR PREPARING THEM AND APPLICATION | CUTA, BCAT2, PTMS | MEN1 1579/4885KMT2A 752/4885BLM 4100/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.